These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
464 related items for PubMed ID: 20429800
1. Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy. Tuomikoski P, Haapalahti P, Sarna S, Ylikorkala O, Mikkola TS. Ann Med; 2010 Jul; 42(5):334-43. PubMed ID: 20429800 [Abstract] [Full Text] [Related]
2. Vasomotor hot flushes and 24-hour ambulatory blood pressure in recently post-menopausal women. Tuomikoski P, Haapalahti P, Ylikorkala O, Mikkola TS. Ann Med; 2010 Apr; 42(3):216-22. PubMed ID: 20384436 [Abstract] [Full Text] [Related]
3. Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial. Bachmann GA, Schaefers M, Uddin A, Utian WH. Obstet Gynecol; 2007 Oct; 110(4):771-9. PubMed ID: 17906008 [Abstract] [Full Text] [Related]
4. A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women. Endrikat J, Graeser T, Mellinger U, Ertan K, Holz C. Maturitas; 2007 Oct 20; 58(2):201-7. PubMed ID: 17889463 [Abstract] [Full Text] [Related]
5. Hot flushes and biochemical markers for cardiovascular disease: a randomized trial on hormone therapy. Tuomikoski P, Mikkola TS, Tikkanen MJ, Ylikorkala O. Climacteric; 2010 Oct 20; 13(5):457-66. PubMed ID: 20443719 [Abstract] [Full Text] [Related]
6. Vasomotor hot flashes and heart rate variability: a placebo-controlled trial of postmenopausal hormone therapy. Lantto H, Haapalahti P, Tuomikoski P, Viitasalo M, Väänänen H, Sovijärvi AR, Ylikorkala O, Mikkola TS. Menopause; 2012 Jan 20; 19(1):82-8. PubMed ID: 21934534 [Abstract] [Full Text] [Related]
7. Effect of hot flushes on cardiovascular autonomic responsiveness: a randomized controlled trial on hormone therapy. Hautamäki H, Haapalahti P, Piirilä P, Tuomikoski P, Sovijärvi A, Ylikorkala O, Mikkola TS. Maturitas; 2012 Jul 20; 72(3):243-8. PubMed ID: 22537767 [Abstract] [Full Text] [Related]
8. Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms. Simon JA, ESTRASORB Study Group. Menopause; 2006 Jul 20; 13(2):222-31. PubMed ID: 16645536 [Abstract] [Full Text] [Related]
9. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study]. Zhou YZ, Sun LZ, Lin JF, Yang X, Zhang LJ, Qiao J, Wang ZH, Xu YX, Xiong ZA, Lin SQ. Zhonghua Fu Chan Ke Za Zhi; 2011 May 20; 46(5):345-9. PubMed ID: 21733370 [Abstract] [Full Text] [Related]
10. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids. Rozenberg S, Ylikorkala O, Arrenbrecht S. Int J Fertil Womens Med; 1997 May 20; 42 Suppl 2():376-87. PubMed ID: 9397385 [Abstract] [Full Text] [Related]
11. Menopausal hot flushes do not associate with changes in heart rate variability in controlled testing: a randomized trial on hormone therapy. Hautamäki H, Mikkola TS, Sovijärvi AR, Piirilä P, Haapalahti P. Acta Obstet Gynecol Scand; 2013 Aug 20; 92(8):902-8. PubMed ID: 23656530 [Abstract] [Full Text] [Related]
12. Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms. Gordon S, Walsh BW, Ciaccia AV, Siddhanti S, Rosen AS, Plouffe L. Obstet Gynecol; 2004 Feb 20; 103(2):267-73. PubMed ID: 14754694 [Abstract] [Full Text] [Related]
13. Gabapentin vs. low-dose transdermal estradiol for treating post-menopausal women with moderate to very severe hot flushes. Aguirre W, Chedraui P, Mendoza J, Ruilova I. Gynecol Endocrinol; 2010 May 20; 26(5):333-7. PubMed ID: 20050764 [Abstract] [Full Text] [Related]
14. Predictors of hot flushes in postmenopausal women who receive raloxifene therapy. Aldrighi JM, Quail DC, Levy-Frebault J, Aguas F, Kosian K, Garrido L, Bosio-Le Goux B, Saráchaga M, Graebe A, Niño AJ, Nickelsen T. Am J Obstet Gynecol; 2004 Dec 20; 191(6):1979-88. PubMed ID: 15592280 [Abstract] [Full Text] [Related]
15. Menopausal hot flushes and vascular health. Tuomikoski P, Ylikorkala O, Mikkola TS. Ann Med; 2011 Jun 20; 43(4):283-91. PubMed ID: 21254907 [Abstract] [Full Text] [Related]
16. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Joffe H, Hall JE, Gruber S, Sarmiento IA, Cohen LS, Yurgelun-Todd D, Martin KA. Menopause; 2006 Jun 20; 13(3):411-22. PubMed ID: 16735938 [Abstract] [Full Text] [Related]
17. Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women. Cacciatore B, Paakkari I, Hasselblatt R, Nieminen MS, Toivonen J, Tikkanen MI, Ylikorkala O. Am J Obstet Gynecol; 2001 Apr 20; 184(5):904-9. PubMed ID: 11303197 [Abstract] [Full Text] [Related]
20. Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese women. Lin SQ, Sun LZ, Lin JF, Yang X, Zhang LJ, Qiao J, Wang ZH, Xu YX, Xiong ZA, Zhou YZ, Wang ML, Zhu J, Chen SR, Su H, Yang CS, Wang SH, Zhang YZ, Dong XJ. Climacteric; 2011 Aug 20; 14(4):472-81. PubMed ID: 21469973 [Abstract] [Full Text] [Related] Page: [Next] [New Search]